Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-5 of 5 (Search time: 0.011 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
15-Jun-2010The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophreniaSelva-Vera, Gabriel; Balanzá-Martínez, Vicent; Salazar-Fraile, José; Sánchez-Moreno, José; Martínez-Arán, Anabel, 1971-; Correa, Patricia; Vieta i Pascual, Eduard, 1963-; Tabarés-Seisdedos, Rafael
2011Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychoticsBernardo Arroyo, Miquel; San Molina, Luis; Olivares Diez, José Manuel; Polavieja, Pepa; Gilaberte Asín, Inmaculada; Álvarez, María; Ciudad, Antonio; Dilla, Tatiana
16-Sep-2013Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study.Ascher-Svanum, Haya; Novick, Diego; Haro Abad, Josep Maria; Bertsch, Jordan; McDonnell, David; Detke, Holland
20-Jun-2014Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection Ascher-Svanum, Haya; Novick, Diego; Haro Abad, Josep Maria; Bertsch, Jordan; McDonnell, David; Detke, Holland
4-Dec-2012Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) studyHong, Jihyung; Novick, Diego; Brugnoli, Roberto; Karagianis, Jamie; Dossenbach, Martin; Haro Abad, Josep Maria